Other
Blood-Brain Barrier
0
Pipeline Programs↗
3
Active Trials↗
1
Companies Involved↗
Blood-Brain Barrier is an early-stage landscape with 0 programs across 1 company. The most active players are Orion Corporation, Orion Pharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed5 · 56%
Recruiting2 · 22%
Not yet recruiting1 · 11%
Unknown status1 · 11%
Clinical Trials
Trial Activity
9 trials
Role of the Blood-Brain Barrier in Stress Resilience: Investigating New Pathways Towards Pharmacological Augmentation of Stress Resilience
Not yet recruiting·LLeibniz-Institut für Resilienzforschung (LIR) gGmbH·N/A·NCT06965868·122 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)